Josimar Oliveira Eloy is a professor at the Federal University of Ceará, Brazil. He earned a Master´s (2012) and P&D (2016) degrees in pharmaceutical sciences from the University of São Paulo, Brazil. He completed postdoctoral training in pharmaceutical sciences at São Paulo State University (2017), Brazil, and is currently at Queen's University, Belfast, United Kingdom. His work field is on pharmaceutical nanotechnology for drug delivery to cancer. He has published 56 articles, 11 book chapters, and 1 patent and served as an editor for one book. He has participated and given lectures at numerous conferences. His research interests include liposomes, nanoparticles, drug delivery, functionalization, monoclonal antibodies, and cancer.
Josimar Oliveira Eloy is a professor at the Federal University of Ceará, Brazil. He earned a Master´s (2012) and P&D (2016) degrees in pharmaceutical sciences from the University of São Paulo, Brazil. He completed postdoctoral training in pharmaceutical sciences at São Paulo State University (2017), Brazil, and is currently at Queen's University, Belfast, United Kingdom. His work field is on pharmaceutical nanotechnology for drug delivery to cancer. He has published 56 articles, 11 book chapters, and 1 patent and served as an editor for one book. He has participated and given lectures at numerous conferences. His research interests include liposomes, nanoparticles, drug delivery, functionalization, monoclonal antibodies, and cancer.